US Government Shutdown Reveals IPO Loophole
Since the United States government shutdown on Wed, Oct 1, 2025, 90% of the US Securities and Exchange Commission (SEC) staff have been furloughed, leading to a reduction in the agency's operations, including the review and approval of IPO registrations.
Since the United States government shutdown on Wed, Oct 1, 2025, 90% of the US Securities and Exchange Commission (SEC) staff have been furloughed, leading to a reduction in the agency's operations, including the review and approval of IPO registrations.
The SEC has announced that companies can proceed with IPOs through an alternative method that allows for automatic approval. This method permits applicants to bypass the pricing information section during the initial review. Applications will still undergo a retroactive review once the SEC resumes full operations.
Regulation: The 20-Day “Automatic Effectiveness” Loophole
Under typical SEC protocols, an IPO registration becomes effective only after a thorough review and resolution of any issues by the SEC. However, a lesser-known procedure allows for automatic effectiveness after 20 days, unless the SEC retroactively objects. Due to the shutdown, the SEC has indicated that companies may use this 20-day automatic effectiveness route, with relaxed enforcement of pricing or price-dependent disclosures during this period.
During the shutdown, issuers are permitted to omit pricing information or other price-dependent sections at the time of filing without immediate penalty. This means companies could list shares before full regulatory scrutiny, with subsequent reviews to follow. Investors should be aware that disclosures are subject to retroactive examination.
The SEC has announced that companies can proceed with IPOs through an alternative method that allows for automatic approval.
Operational Impact: Avoiding a Backlog
With the SEC operating with limited personnel, new IPO reviews and comment cycles are largely on hold. Although the EDGAR filing portal remains open, the SEC has stated it cannot issue “effectiveness” notices or address most review comments during the shutdown. Companies with critical IPO timelines, particularly in fast-moving sectors like biotech or high-growth technology, may face significant delays if they wait for full SEC processing.
Utilizing the 20-day effectiveness route allows issuers to maintain momentum, sustain investor interest, and preserve valuation opportunities, avoiding potential market timing issues.
Bypassing initial SEC checks carries inherent risks. Companies remain legally accountable for any disclosure inaccuracies or omissions, with the SEC retaining the right to demand amendments, impose penalties, or initiate enforcement actions. Despite the possibility of retrospective review, issuers must ensure the accuracy of their disclosures.
Investors may view IPOs lacking the conventional SEC pre-trading validation as higher risk, potentially impacting market valuation. The absence of regulatory oversight might result in lower valuations or increased legal exposure for issuers.
Historical Context and Market Implications
Similar tactics have been employed during previous government shutdowns. However, the current scale and market conditions differ, with the IPO market in 2025 experiencing a revival. Should many companies adopt this loophole, the post-shutdown backlog could be substantial, but the delay impact may be lessened. The prolonged shutdown may increase pressure for regulatory enforcement and investor scrutiny.
Based on reporting by techround.co.uk.